SMI-01

SMI-01 · Sofregen Medical, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SMI-01, covering 2024-05-31 to 2024-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler [NA]